$599

Camurus and Lilly Expand Partnership; Merck Ph2 Oral PCSK9i + Lp(a) FDC; AZ Ph3 Laroprovstat + Rosuvastatin FDC Studies; MiniMed Flex Pre-Order Available; Ilant Series A Financing

A series of cardiometabolic-related news items has been observed from Lilly/Camurus, Merck, AstraZeneca, MiniMed, and Ilant Health. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Already a member? Log in here